Autologous Therapy

MedTech

PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026

SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...

By cGxPwire Editor
September 30, 2026

Bio-Pharma

Matricelf Gains FDA Feedback for NewRal Spinal Injury Trial

Ness Ziona, Israel, September 3, 2026 Matricelf Ltd., a regenerative medicine company developing personalized engineered tissue therapies, has received...

By cGxPwire Editor
September 8, 2026

.VC

Aspen Neuroscience Secures $115M to Advance Cell Therapy

SAN DIEGO, CA — November 20, 2025 — Aspen Neuroscience, a leading developer of personalized autologous cell therapies for...

By cGxPwire Editor
November 21, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Autologous Therapy

PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026

Matricelf Gains FDA Feedback for NewRal Spinal Injury Trial

Aspen Neuroscience Secures $115M to Advance Cell Therapy